Please Enable JavaScript

www.cablinginstall.comis using a security service for protection against online attacks.
The service requires full JavaScript support in order to view this website.

Please enable JavaScript on your browser and try again.

www.cablinginstall.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Astrazeneca Plc Ord (OP: AZNCF )

155.48 UNCHANGED

Streaming Delayed Price Updated: 2:42 PM EDT, Jul 25, 2024 Add to My Watchlist

Price and Volume

Volume	112
Open	155.48
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	155.48
Today's Range	155.48 - 155.48
52wk Range	118.16 - 165.22
Shares Outstanding	N/A
Dividend Yield	N/A

Chart for (: )

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

3 stocks that crushed earnings estimates and still tanked

November 20, 2023

Every earnings season, regardless of sector or industry, has its share of stocks that go down even after beating earnings expectations such as these stocks

AstraZeneca Abandons Blood Cancer, Cardiovascular Programs Amid Portfolio Prioritization

July 28, 2023

Earlier today, AstraZeneca plc (NASDAQ: AZN)

Performance

YTD	+17.07%	+17.07%
1 Month	-1.52%	-1.52%
3 Month	+6.45%	+6.45%
6 Month	+17.75%	+17.75%
1 Year	+10.66%	+10.66%

More News

AstraZeneca Q2 Earnings Beat Consensus Despite Zero COVID-19 Vaccine Sales, Stock Shoots Up

July 28, 2023

AstraZeneca-Sanofi's Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants

July 18, 2023

AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial

July 03, 2023

AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer

June 29, 2023

AstraZeneca Seeks Expanded Use For Soliris As First Targeted Therapy For Pediatric Patients With Autoimmune Neuromuscular Disease

June 26, 2023

Why Are Pieris Pharmaceuticals Shares Tanking Today

June 21, 2023

AstraZeneca Mulls China Business Unit Spin-Off Amid Geopolitical Tensions

June 20, 2023

AstraZeneca's Add On Treatment With Standard Care Improves Hemoglobin Levels In Rare Blood Disorder

June 09, 2023

AstraZeneca Inks Over $2B Agreement For Cell Therapies Targeting Diabetes

June 09, 2023

Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon

June 09, 2023

AstraZeneca's Tagrisso Significantly Enhances Survival in Certain Post Surgery Non-Small Cell Lung Cancer Patients

June 05, 2023

AstraZeneca/Merck's Cancer Drug Combo Shows Positive Results In Endometrial Cancer

May 26, 2023

AstraZeneca's China Executive Seeks Loyalty to "Love the Communist Party" In China

May 19, 2023

One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps

May 17, 2023

AstraZeneca' Tagrisso/Chemo Combo Therapy Delays Treatment Resistance, Disease Progression In Certain Type Of Advanced Lung Cancer

May 17, 2023

Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody

May 12, 2023

FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck's Prostate Cancer Drug

May 01, 2023

FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting

April 27, 2023

AstraZeneca's COVID-19 Vaccine Loses Shine, Cancer Drug Imfinzi & Emerging Markets Stabilize Q1 Revenues

April 27, 2023

AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression

April 24, 2023

Why AstraZeneca Shares Are Trading Higher Today?

April 18, 2023

Canadian Cancer Diagnostic Company BioMark Working On Early Lung Detection Assay

April 10, 2023

AstraZeneca' Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study

April 05, 2023

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.